Powering intelligent bioanalysis

We provide the life science community with world-class instruments and services delivering more relevant information and improved insights from bioanalysis

Attana Research & Development
Attana Diagnostics

Validated and trusted by internationally
renowned companies and institutions

0
years of experience
0 +
publications enabled

Bioanalysis tailored to your needs

Attana
Research & Development

• Contract Research services

• Biosensor instruments and related supplies
Explore

Attana
Diagnostics

• Attana Virus Analytics (AVA)

• Generic diagnostic platform
Explore

Select publications enabled by Attana

We work closely with academic institutions and research teams worldwide to assist in new discoveries and innovation. To date, we have enabled more than 130 publications across a wide variety of scientific fields.

View all scientific resources
Targeting human cancer
Salanti et al.
University of Copenhagen
Cancer Cell 28, 500–514 October 12, 2015
Read more
Characterization of corona nanoparticle interactions
M. Gianneli, E. Polo, H. Lopez, V. Castagnola, T. Aastrup & K.A. Dawson
Nanoscale, vol. 10, 2018, p. 5474-5481
Read more
Potential cancer vaccine using a novel virus-like particle
Arianna Palladini et al.
OncoImmunology, Volume 7, Issue 30, 2018
Read more
Suppressing cancer growth with novel bispecific antibodies
Prof. Roland Kontermann
Institute of Cell Biology and Immunology
University of Stuttgart
Mol Cancer Ther 2020;19:1474–85
Read more
Previous
Next

Our latest news updates

Read more news
Swedish news room

Event calendar

2020-12-02

Stora Aktiedagen 2020

09.00-09.30, CEO Teodor Aastrup will present details about the upcoming rights issue and our plans for 2021.

Live stream

December 2020

Rights
issue

Subscription period:
December 3rd - 17th

Follow the link to learn more about our upcoming rights issue

Read more
View past events & presentations